Nine Chapters Capital Management’s Edwards Lifesciences EW Stock Holding History

Nine Chapters Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-107,400	Closed	-$2.54M	–	185
2015 Q3	$2.54M	Buy	+107,400	New	+$2.59M	0.22%	115
2015 Q2	–	Sell	-82,200	Closed	-$1.95M	–	1015
2015 Q1	$1.95M	Sell	82,200 -112,800	-58%	-$2.53M	0.17%	174
2014 Q4	$4.14M	Buy	+195,000	New	+$3.92M	0.36%	57

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Nine Chapters Capital Management's EW Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Edwards Lifesciences (EW) in Q4 2015, closing a stake of 107,400 shares — an estimated $2.54M sold.

Nine Chapters Capital Management first reported a position in EW in Q4 2014 and held it in 3 quarters. The position peaked at $4.14M in Q4 2014. 605 funds tracked by Wall St. Rank hold EW as of Q4 2015.

Nine Chapters Capital Management reported no remaining Edwards Lifesciences position as of Q4 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 107,400 Edwards Lifesciences shares in Q4 2015, an estimated $2.54M.
Nine Chapters Capital Management first reported a position in Edwards Lifesciences in Q4 2014 and held it in 3 quarters.
Nine Chapters Capital Management's Edwards Lifesciences position peaked at $4.14M in Q4 2014.
605 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.